Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DermTech, Inc.DMTK · Entity 89998 | Director | June 01, 2023 | June 05, 2023 |
| RAPID MICRO BIOSYSTEMS, INC.RPID · Entity 6966 | Director | May 29, 2026 | June 02, 2026 |
| VivoSim Labs, INC.ONVO · Entity 8386 | Director | September 05, 2019 | September 09, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DermTech, Inc.
Report date June 01, 2023 · Filed June 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 86,459 |
Reported balance
After 2023-06-01 transaction · row 1
1 source rowRow 1 · 2023-06-01 · Grant · Acquired 35,714 · Balance 86,459 F1: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service. The shares underlying any vested restricted stock units shall be released to the reporting person on June 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service. The shares underlying any vested restricted stock units shall be released to the reporting person on June 1, 2024.
RAPID MICRO BIOSYSTEMS, INC.
Report date May 29, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 60,687 |
Reported balance
After 2026-05-29 transaction · row 1
1 source rowRow 1 · 2026-05-29 · Grant · Acquired 12,787 · Balance 60,687 F1: On May 29, 2026, the Reporting Person purchased, in a registered direct offering, 12,787 shares of the Issuer's Class A Common Stock, as well as an accompanying Series A Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof) and an accompanying Series B Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof). The purchase price of each share of Issuer Class A Common Stock and accompanying Series A and Series B Warrant was $1.955. The issuance of such securities was approved by the Issuer's compensation committee of the board of directors in accordance with Rule 16(b)-3 of the Securities Exchange Act of 1934, as amended. |
| Series A Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.96 · Expires 2027-05-29 | Direct | 12,787 |
Reported balance
After 2026-05-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-29 · Grant · Acquired 12,787 · Balance 12,787 F1: On May 29, 2026, the Reporting Person purchased, in a registered direct offering, 12,787 shares of the Issuer's Class A Common Stock, as well as an accompanying Series A Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof) and an accompanying Series B Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof). The purchase price of each share of Issuer Class A Common Stock and accompanying Series A and Series B Warrant was $1.955. The issuance of such securities was approved by the Issuer's compensation committee of the board of directors in accordance with Rule 16(b)-3 of the Securities Exchange Act of 1934, as amended. F3: The Series A and Series B Warrants cannot be exercised for shares of the Issuer's Class A Common Stock if, as a result of such exercise, the holder, together with its affiliates and any other persons whose beneficial ownership would be aggregated for purposes of Section 13(d) of the Act, would beneficially own more than 4.99% of the total number of shares of the Issuer's Class A Common Stock then outstanding immediately following such exercise. |
| Series B Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.34 · Expires 2031-05-29 | Direct | 12,787 |
Reported balance
After 2026-05-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-05-29 · Grant · Acquired 12,787 · Balance 12,787 F1: On May 29, 2026, the Reporting Person purchased, in a registered direct offering, 12,787 shares of the Issuer's Class A Common Stock, as well as an accompanying Series A Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof) and an accompanying Series B Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof). The purchase price of each share of Issuer Class A Common Stock and accompanying Series A and Series B Warrant was $1.955. The issuance of such securities was approved by the Issuer's compensation committee of the board of directors in accordance with Rule 16(b)-3 of the Securities Exchange Act of 1934, as amended. F3: The Series A and Series B Warrants cannot be exercised for shares of the Issuer's Class A Common Stock if, as a result of such exercise, the holder, together with its affiliates and any other persons whose beneficial ownership would be aggregated for purposes of Section 13(d) of the Act, would beneficially own more than 4.99% of the total number of shares of the Issuer's Class A Common Stock then outstanding immediately following such exercise. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Trust | 10,000 |
Reported balance
Holding disclosure · report date 2026-05-29 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,000 F2: Shares held in family trust as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 29, 2026, the Reporting Person purchased, in a registered direct offering, 12,787 shares of the Issuer's Class A Common Stock, as well as an accompanying Series A Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof) and an accompanying Series B Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof). The purchase price of each share of Issuer Class A Common Stock and accompanying Series A and Series B Warrant was $1.955. The issuance of such securities was approved by the Issuer's compensation committee of the board of directors in accordance with Rule 16(b)-3 of the Securities Exchange Act of 1934, as amended.
F2: Shares held in family trust as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
F3: The Series A and Series B Warrants cannot be exercised for shares of the Issuer's Class A Common Stock if, as a result of such exercise, the holder, together with its affiliates and any other persons whose beneficial ownership would be aggregated for purposes of Section 13(d) of the Act, would beneficially own more than 4.99% of the total number of shares of the Issuer's Class A Common Stock then outstanding immediately following such exercise.
VivoSim Labs, INC.
Report date September 05, 2019 · Filed September 09, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.27 · Expires 2029-09-05 | Direct | 52,000 |
Reported balance
After 2019-09-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-09-05 · Grant · Acquired 52,000 · Balance 52,000 F1: The option represents an automatic annual award granted pursuant to the Issuer's non-employee director compensation plan. The option shares vest and become exercisable in full on the earlier of (i) September 5, 2020 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: The option represents an automatic annual award granted pursuant to the Issuer's non-employee director compensation plan. The option shares vest and become exercisable in full on the earlier of (i) September 5, 2020 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NanoString Technologies Inc
Report date May 06, 2024 · Filed May 08, 2024
Section 16 reporting ended · disclosed 2024-05-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 65,384 |
Reported balance
After 2024-05-06 transaction · row 1
1 source rowRow 1 · 2024-05-06 · Exercise / conversion · Acquired 41,133 · Balance 65,384 F1: The shares have not been delivered to the reporting person. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-05-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-05-06 · Exercise / conversion · Disposed 41,133 · Balance 0 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F3: Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a "Change of Control" under the terms of the RSU award agreement, the vesting of the RSUs accelerated. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares have not been delivered to the reporting person.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.
F3: Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a "Change of Control" under the terms of the RSU award agreement, the vesting of the RSUs accelerated.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2026 Filed Jun 2, 2026 23:42 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantSeries B Warrant (right to buy) · Derivative | 12,787 | $0.00 Strike: $2.34 | $0.00 |
DisclosureSEC source: 0001326794-26-000007 · wk-form4_1780443754.xml · derivative · entry 4 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,787 Underlying: Class A Common Stock · 12,787 shares Expires 2031-05-29 F1 · kind: On May 29, 2026, the Reporting Person purchased, in a registered direct offering, 12,787 shares of the Issuer's Class A Common Stock, as well as an accompanying Series A Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof) and an accompanying Series B Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof). The purchase price of each share of Issuer Class A Common Stock and accompanying Series A and Series B Warrant was $1.955. The issuance of such securities was approved by the Issuer's compensation committee of the board of directors in accordance with Rule 16(b)-3 of the Securities Exchange Act of 1934, as amended. F1 · price: On May 29, 2026, the Reporting Person purchased, in a registered direct offering, 12,787 shares of the Issuer's Class A Common Stock, as well as an accompanying Series A Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof) and an accompanying Series B Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof). The purchase price of each share of Issuer Class A Common Stock and accompanying Series A and Series B Warrant was $1.955. The issuance of such securities was approved by the Issuer's compensation committee of the board of directors in accordance with Rule 16(b)-3 of the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: The Series A and Series B Warrants cannot be exercised for shares of the Issuer's Class A Common Stock if, as a result of such exercise, the holder, together with its affiliates and any other persons whose beneficial ownership would be aggregated for purposes of Section 13(d) of the Act, would beneficially own more than 4.99% of the total number of shares of the Issuer's Class A Common Stock then outstanding immediately following such exercise. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 23:42 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantSeries A Warrant (right to buy) · Derivative | 12,787 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001326794-26-000007 · wk-form4_1780443754.xml · derivative · entry 3 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,787 Underlying: Class A Common Stock · 12,787 shares Expires 2027-05-29 F1 · kind: On May 29, 2026, the Reporting Person purchased, in a registered direct offering, 12,787 shares of the Issuer's Class A Common Stock, as well as an accompanying Series A Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof) and an accompanying Series B Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof). The purchase price of each share of Issuer Class A Common Stock and accompanying Series A and Series B Warrant was $1.955. The issuance of such securities was approved by the Issuer's compensation committee of the board of directors in accordance with Rule 16(b)-3 of the Securities Exchange Act of 1934, as amended. F1 · price: On May 29, 2026, the Reporting Person purchased, in a registered direct offering, 12,787 shares of the Issuer's Class A Common Stock, as well as an accompanying Series A Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof) and an accompanying Series B Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof). The purchase price of each share of Issuer Class A Common Stock and accompanying Series A and Series B Warrant was $1.955. The issuance of such securities was approved by the Issuer's compensation committee of the board of directors in accordance with Rule 16(b)-3 of the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: The Series A and Series B Warrants cannot be exercised for shares of the Issuer's Class A Common Stock if, as a result of such exercise, the holder, together with its affiliates and any other persons whose beneficial ownership would be aggregated for purposes of Section 13(d) of the Act, would beneficially own more than 4.99% of the total number of shares of the Issuer's Class A Common Stock then outstanding immediately following such exercise. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 23:42 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantClass A Common Stock | 12,787 | $1.96 | $24,998.59 |
DisclosureSEC source: 0001326794-26-000007 · wk-form4_1780443754.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,687 F1 · kind: On May 29, 2026, the Reporting Person purchased, in a registered direct offering, 12,787 shares of the Issuer's Class A Common Stock, as well as an accompanying Series A Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof) and an accompanying Series B Warrant to purchase 12,787 shares of the Issuer's Class A Common Stock (or pre-funded warrants in lieu thereof). The purchase price of each share of Issuer Class A Common Stock and accompanying Series A and Series B Warrant was $1.955. The issuance of such securities was approved by the Issuer's compensation committee of the board of directors in accordance with Rule 16(b)-3 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 21, 2026 Filed May 26, 2026 23:27 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantStock Option (Right to Buy) · Derivative | 38,700 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001326794-26-000003 · wk-form4_1779838019.xml · derivative · entry 3 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,700 Underlying: Class A Common Stock · 38,700 shares Expires 2036-05-20 F3 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date. Read SEC document |
| May 21, 2026 Filed May 26, 2026 23:27 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantClass A Common Stock | 19,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001326794-26-000003 · wk-form4_1779838019.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,900 F1 · shares: Grant of restricted stock units ("RSUs") that vests in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:29 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GiftClass A Common Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001380106-25-000203 · wk-form4_1763501372.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,600 F1 · kind: The transaction reported involved a gift by the reporting person of shares of the Company's Class A Common Stock to a non-profit charitable organization. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:09 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantStock Option (Right to Buy) · Derivative | 28,650 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001380106-25-000129 · wk-form4_1748390934.xml · derivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,650 Underlying: Class A Common Stock · 28,650 shares Expires 2035-05-21 F2 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:09 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantClass A Common Stock | 14,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001380106-25-000129 · wk-form4_1748390934.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,600 F1 · shares: Grant of restricted stock units ("RSUs") that vests in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date. Read SEC document |
| August 08, 2024 Filed Aug 9, 2024 12:36 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | PurchaseClass A Common Stock | 50,000 | $0.91 | $45,335.00 |
DisclosureSEC source: 0001380106-24-000182 · wk-form4_1723206977.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,300 F1 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.8100 to $0.9200 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 23, 2024 Filed May 28, 2024 23:01 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantStock Option (Right to Buy) · Derivative | 28,650 | $0.00 Strike: $0.82 | $0.00 |
DisclosureSEC source: 0001380106-24-000142 · wk-form4_1716937283.xml · derivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,650 Underlying: Class A Common Stock · 28,650 shares Expires 2034-05-22 F2 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date. Read SEC document |
| May 23, 2024 Filed May 28, 2024 23:01 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantClass A Common Stock | 14,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001380106-24-000142 · wk-form4_1716937283.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,300 F1 · shares: Grant of restricted stock units ("RSUs") that vests in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:47 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionRestricted Stock Units · Derivative | 41,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001401708-24-000083 · wk-form4_1715215649.xml · derivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,133 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F3 · derivative.exercise_date: Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a "Change of Control" under the terms of the RSU award agreement, the vesting of the RSUs accelerated. F3 · derivative.expiration_date: Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a "Change of Control" under the terms of the RSU award agreement, the vesting of the RSUs accelerated. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:47 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 41,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001401708-24-000083 · wk-form4_1715215649.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares have not been delivered to the reporting person. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 22:51 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantClass A Common Stock · Derivative | 50,000 | $0.00 Strike: $0.97 | $0.00 |
DisclosureSEC source: 0001380106-23-000136 · wf-form4_168972065052790.xml · derivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2033-07-13 F1 · derivative.exercise_date: This option vests and becomes exercisable, subject to the Reporting Person's continued service to the Issuer's Board, in 36 substantially equal monthly installments with the first installment vesting on August 14, 2023. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 17:48 UTC | NanoString Technologies Inc NSTG · Entity 15988 | GrantRestricted Stock Units · Derivative | 41,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001401708-23-000174 · wf-form4_168790250436295.xml · derivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,133 Underlying: Common Stock · 41,133 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F2 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 23, 2023 or on the date immediately prior to the 2024 annual meeting of stockholders. F2 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 23, 2023 or on the date immediately prior to the 2024 annual meeting of stockholders. Read SEC document |
| June 17, 2023 Filed Jun 20, 2023 16:16 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionRestricted Stock Units · Derivative | 14,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001401708-23-000139 · wf-form4_168729219675319.xml · derivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,851 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F2 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 17, 2022 or on the date immediately prior to the 2023 annual meeting of stockholders. F2 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 17, 2022 or on the date immediately prior to the 2023 annual meeting of stockholders. Read SEC document |
| June 17, 2023 Filed Jun 20, 2023 16:16 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 14,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001401708-23-000139 · wf-form4_168729219675319.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:27 UTC | DermTech, Inc. DMTK · Entity 89998 | GrantCommon Stock | 35,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034594 · doc4.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,459 F1 · shares: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service. The shares underlying any vested restricted stock units shall be released to the reporting person on June 1, 2024. Read SEC document |
| July 18, 2022 Filed Jul 21, 2022 00:14 UTC | DermTech, Inc. DMTK · Entity 89998 | GrantCommon Stock | 19,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042799 · doc4.xml · nonDerivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,745 F2 · shares: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in one installment on May 26, 2023. The shares underlying the restricted stock units shall be released to the reporting person, on January 2, 2024, subject to the reporting person's continued service. Read SEC document |
| July 18, 2022 Filed Jul 21, 2022 00:14 UTC | DermTech, Inc. DMTK · Entity 89998 | GrantCommon Stock | 26,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042799 · doc4.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,885 F1 · shares: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in three equal annual installments over the three-year period following the grant date, subject to the reporting person's continued service. The release dates for vested shares underlying the RSUs shall be the first business day in January of the year following each vesting date, respectively. Read SEC document |
| June 17, 2022 Filed Jun 17, 2022 17:09 UTC | NanoString Technologies Inc NSTG · Entity 15988 | GrantRestricted Stock Units · Derivative | 14,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001401708-22-000123 · wf-form4_165550013388642.xml · derivative · entry 3 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,851 Underlying: Common Stock · 14,851 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F3 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 17, 2022 or on the date immediately prior to the 2023 annual meeting of stockholders. F3 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 17, 2022 or on the date immediately prior to the 2023 annual meeting of stockholders. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 17:09 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionRestricted Stock Units · Derivative | 3,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001401708-22-000123 · wf-form4_165550013388642.xml · derivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,890 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F2 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. F2 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 17:09 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 3,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001401708-22-000123 · wf-form4_165550013388642.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 16:35 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionStock Option (right to buy) · Derivative | 1,500 | $22.30 Strike: $22.30 | $33,450.00 |
DisclosureSEC source: 0001401708-21-000212 · wf-form4_163173810097470.xml · derivative · entry 5 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,111 Underlying: Common Stock · 1,500 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the shares subject to the Option vest on the one year anniversary of January 1, 2017. The vesting of shares subject to the Option will accelerate in full upon a "change in control" as defined in the 2013 Equity Incentive Plan. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 16:35 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionStock Option (right to buy) · Derivative | 1,500 | $16.36 Strike: $16.36 | $24,540.00 |
DisclosureSEC source: 0001401708-21-000212 · wf-form4_163173810097470.xml · derivative · entry 4 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,435 Underlying: Common Stock · 1,500 shares Expires 2026-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 50% of the shares subject to the Option vest on the one year anniversary of September 12, 2016 (the "Vesting Commencement Date") and thereafter the remaining 50% of the total shares vest in twelve equal monthly installments on each monthly anniversary of the Vesting Commencement Date, subject to continued service as a director through each vesting date. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 16:35 UTC | NanoString Technologies Inc NSTG · Entity 15988 | SaleCommon Stock | 3,000 | $59.37 | $178,110.00 |
DisclosureSEC source: 0001401708-21-000212 · wf-form4_163173810097470.xml · nonDerivative · entry 3 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,510 F1 · kind: The sales reported by Dr. Malloy were effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2021. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 16:35 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 1,500 | $22.30 | $33,450.00 |
DisclosureSEC source: 0001401708-21-000212 · wf-form4_163173810097470.xml · nonDerivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 16:35 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 1,500 | $16.36 | $24,540.00 |
DisclosureSEC source: 0001401708-21-000212 · wf-form4_163173810097470.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 17:09 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionStock Options (right to buy) · Derivative | 1,500 | $26.45 Strike: $26.45 | $39,675.00 |
DisclosureSEC source: 0001401708-21-000199 · wf-form4_162932094510974.xml · derivative · entry 3 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,357 Underlying: Common Stock · 1,500 shares Expires 2029-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares subject to the Option vest on the earlier of the one year anniversary of June 18, 2019 or on the date immediately prior to the 2020 annual meeting of stockholders. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 17:09 UTC | NanoString Technologies Inc NSTG · Entity 15988 | SaleCommon Stock | 1,500 | $55.82 | $83,730.00 |
DisclosureSEC source: 0001401708-21-000199 · wf-form4_162932094510974.xml · nonDerivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,510 F1 · kind: The sales reported by Dr. Malloy were effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2021. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 17:09 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 1,500 | $26.45 | $39,675.00 |
DisclosureSEC source: 0001401708-21-000199 · wf-form4_162932094510974.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Oct 21, 2021 16:29 UTC Amendment | NanoString Technologies Inc NSTG · Entity 15988 | SaleCommon Stock | 2,500 | $55.82 | $139,550.00 |
DisclosureSEC source: 0001401708-21-000215 · wf-form4a_163484811964853.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,510 F1 · kind: The sales reported by Dr. Malloy were effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2021. F2 · shares: The Form 4 filed on August 18, 2021 inadvertently misstated the number of securities disposed of. The number reported in Column 4 of this Form 4/A represents the correct number of securities disposed of on August 16, 2021 and the number reported in column 5 of this Form 4/A represents the amount of securities beneficially owned by the Reporting Person as of August 16, 2021. F2 · balance_after: The Form 4 filed on August 18, 2021 inadvertently misstated the number of securities disposed of. The number reported in Column 4 of this Form 4/A represents the correct number of securities disposed of on August 16, 2021 and the number reported in column 5 of this Form 4/A represents the amount of securities beneficially owned by the Reporting Person as of August 16, 2021. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 16:38 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionStock Options (right to buy) · Derivative | 1,500 | $23.34 Strike: $23.34 | $35,010.00 |
DisclosureSEC source: 0001401708-21-000188 · wf-form4_162638149407778.xml · derivative · entry 3 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,910 Underlying: Common Stock · 1,500 shares Expires 2029-03-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares subject to the Option vest on the the date prior to the day of the Company's 2019 annual meeting of stockholders. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 16:38 UTC | NanoString Technologies Inc NSTG · Entity 15988 | SaleCommon Stock | 1,500 | $61.16 | $91,740.00 |
DisclosureSEC source: 0001401708-21-000188 · wf-form4_162638149407778.xml · nonDerivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,510 F1 · kind: The sales reported by Dr. Malloy were effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2021. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 16:38 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 1,500 | $23.34 | $35,010.00 |
DisclosureSEC source: 0001401708-21-000188 · wf-form4_162638149407778.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 19:04 UTC | NanoString Technologies Inc NSTG · Entity 15988 | GrantCommon Stock · Derivative | 3,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001401708-21-000180 · wf-form4_162397099742602.xml · derivative · entry 3 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,890 Underlying: Common Stock · 3,890 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F3 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. F3 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 19:04 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock · Derivative | 5,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001401708-21-000180 · wf-form4_162397099742602.xml · derivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F2 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders. F2 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 19:04 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 5,520 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001401708-21-000180 · wf-form4_162397099742602.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 16:34 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionStock Options (right to buy) · Derivative | 168 | $7.47 Strike: $7.47 | $1,254.96 |
DisclosureSEC source: 0001401708-21-000155 · wf-form4_162378919838315.xml · derivative · entry 3 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 168 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares subject to the Option vest on the one year anniversary of January 1, 2018. The vesting of shares subject to the Option will accelerate in full upon a "change in control" as defined in the 2013 Equity Incentive Plan. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 16:34 UTC | NanoString Technologies Inc NSTG · Entity 15988 | SaleCommon Stock | 168 | $60.05 | $10,088.40 |
DisclosureSEC source: 0001401708-21-000155 · wf-form4_162378919838315.xml · nonDerivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990 F1 · kind: The sales reported by Mr. Malloy were effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2021. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 16:34 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 168 | $7.47 | $1,254.96 |
DisclosureSEC source: 0001401708-21-000155 · wf-form4_162378919838315.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 16:24 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionStock Option (right to buy) · Derivative | 1,500 | $16.36 Strike: $16.36 | $24,540.00 |
DisclosureSEC source: 0001401708-21-000144 · wf-form4_162085102601493.xml · derivative · entry 3 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,935 Underlying: Common Stock · 1,500 shares Expires 2026-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 50% of the shares subject to the Option vest on the one year anniversary of September 12, 2016 (the "Vesting Commencement Date") and thereafter the remaining 50% of the total shares vest in twelve equal monthly installments on each monthly anniversary of the Vesting Commencement Date, subject to continued service as a director through each vesting date. Read SEC document |
| May 10, 2021 Filed May 12, 2021 16:24 UTC | NanoString Technologies Inc NSTG · Entity 15988 | SaleCommon Stock | 1,500 | $63.65 | $95,475.00 |
DisclosureSEC source: 0001401708-21-000144 · wf-form4_162085102601493.xml · nonDerivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990 F1 · kind: The sales reported by Mr. Malloy were effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2021. Read SEC document |
| May 10, 2021 Filed May 12, 2021 16:24 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 1,500 | $16.36 | $24,540.00 |
DisclosureSEC source: 0001401708-21-000144 · wf-form4_162085102601493.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:19 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionStock Options (right to buy) · Derivative | 1,000 | $7.47 Strike: $7.47 | $7,470.00 |
DisclosureSEC source: 0001401708-21-000062 · wf-form4_161541116852683.xml · derivative · entry 5 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168 Underlying: Common Stock · 1,000 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the shares subject to the Option vest on the one year anniversary of January 1, 2018. The vesting of shares subject to the Option will accelerate in full upon a "change in control" as defined in the 2013 Equity Incentive Plan. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:19 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionStock Option (right to buy) · Derivative | 1,500 | $16.36 Strike: $16.36 | $24,540.00 |
DisclosureSEC source: 0001401708-21-000062 · wf-form4_161541116852683.xml · derivative · entry 4 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,435 Underlying: Common Stock · 1,500 shares Expires 2026-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 50% of the shares subject to the Option vest on the one year anniversary of September 12, 2016 (the "Vesting Commencement Date") and thereafter the remaining 50% of the total shares vest in twelve equal monthly installments on each monthly anniversary of the Vesting Commencement Date, subject to continued service as a director through each vesting date. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:19 UTC | NanoString Technologies Inc NSTG · Entity 15988 | SaleCommon Stock | 2,500 | $63.14 | $157,850.00 |
DisclosureSEC source: 0001401708-21-000062 · wf-form4_161541116852683.xml · nonDerivative · entry 3 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990 F1 · kind: The sales reported by Dr. Malloy were effected pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2020. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:19 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 1,000 | $7.47 | $7,470.00 |
DisclosureSEC source: 0001401708-21-000062 · wf-form4_161541116852683.xml · nonDerivative · entry 2 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:19 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionCommon Stock | 1,500 | $16.36 | $24,540.00 |
DisclosureSEC source: 0001401708-21-000062 · wf-form4_161541116852683.xml · nonDerivative · entry 1 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 16:36 UTC | NanoString Technologies Inc NSTG · Entity 15988 | Exercise / conversionStock Option (right to buy) · Derivative | 1,500 | $16.36 Strike: $16.36 | $24,540.00 |
DisclosureSEC source: 0001401708-21-000004 · wf-form4_161057377155904.xml · derivative · entry 5 Malloy Kirk · CIK 0001326794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,935 Underlying: Common Stock · 1,500 shares Expires 2026-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 50% of the shares subject to the Option vest on the one year anniversary of September 12, 2016 (the "Vesting Commencement Date") and thereafter the remaining 50% of the total shares vest in twelve equal monthly installments on each monthly anniversary of the Vesting Commencement Date, subject to continued service as a director through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.